A new report shows while cancer death rates among Black people are declining, they remain higher than other racial and ethnic ...

Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

Topline: Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker ...

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Traditional therapies targeting ... Study Finds New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients Dec. 11, 2024 — A new study found that a DNA sequencing test for advanced ...

For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...

Many Medicare patients with advanced cancer receive potentially aggressive treatment at the expense of supportive care, according to a study that analyzed Medicare records.

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are contributing to up to half of patients not getting the right treatment for ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...